Personalis, Inc.
(NASDAQ: PSNL)

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

6.720 -

+0.130 (+1.97%)
Range 6.651 - 7.105   (6.83%)
Open 6.660
Previous Close 6.590
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 1,988,284
Value 10,884,481
Remark -
Delayed prices. Updated at 14 Mar 2026 08:00.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis